Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,719,236
  • Shares Outstanding, K 27,770
  • Annual Sales, $ 10,440 K
  • Annual Income, $ -166,900 K
  • 36-Month Beta 2.55
  • Price/Sales 334.51
  • Price/Cash Flow N/A
  • Price/Book 7.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -2.13
  • Number of Estimates 1
  • High Estimate -2.13
  • Low Estimate -2.13
  • Prior Year -2.18
  • Growth Rate Est. (year over year) +2.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
125.50 +6.72%
on 08/07/18
150.41 -10.96%
on 07/19/18
-14.08 (-9.51%)
since 07/16/18
3-Month
125.50 +6.72%
on 08/07/18
164.76 -18.71%
on 06/01/18
-16.75 (-11.12%)
since 05/16/18
52-Week
96.42 +38.90%
on 09/29/17
164.76 -18.71%
on 06/01/18
+31.06 (+30.19%)
since 08/16/17

Most Recent Stories

More News
Big Businesses Look for Healthier Alternatives to Smoking for Drug Delivery

NetworkNewsWire Editorial Coverage

MO : 60.83 (+1.08%)
BTI : 53.09 (+0.28%)
GWPH : 133.93 (+1.04%)
LXRP : 1.7100 (-1.72%)
LXX.CN : 2.290 (-0.43%)
PM : 84.68 (+1.52%)
Micron, Ultra Clean Holdings, Scotts Miracle-Gro, GW Pharmaceuticals, Innovative Industrial Properties, Molson Coors and Constellation Brands highlighted as Zacks Bull and Bear of the Day

Micron, Ultra Clean Holdings, Scotts Miracle-Gro, GW Pharmaceuticals, Innovative Industrial Properties, Molson Coors and Constellation Brands highlighted as Zacks Bull and Bear of the Day

IIPR : 34.43 (-2.02%)
TAP : 67.89 (+1.06%)
STZ : 202.48 (-2.78%)
MU : 47.10 (-0.82%)
UCTT : 13.21 (-0.23%)
GWPH : 133.93 (+1.04%)
SMG : 75.10 (+1.31%)
Where to Find the Best Marijuana Stocks

The marijuana industry continues to grow and so do the investing opportunities. Where can you find them now?

IIPR : 34.43 (-2.02%)
TAP : 67.89 (+1.06%)
STZ : 202.48 (-2.78%)
GWPH : 133.93 (+1.04%)
SMG : 75.10 (+1.31%)
Where to Find the Best Marijuana Stocks

The marijuana industry continues to grow and so do the investing opportunities. Where can you find them now?

IIPR : 34.43 (-2.02%)
TAP : 67.89 (+1.06%)
STZ : 202.48 (-2.78%)
GWPH : 133.93 (+1.04%)
SMG : 75.10 (+1.31%)
GW Pharma (GWPH) Q3 Earnings: Is a Turnaround in the Cards?

GW Pharma (GWPH) is expected to report its fiscal third-quarter results next week. Investors focus is expected to be on the commercialization plan for Epidiolex.

BLFS : 19.29 (-1.88%)
GWPH : 133.93 (+1.04%)
CHRS : 18.75 (+1.90%)
OMER : 20.53 (+1.94%)
Lexaria's DehydraTECH Triples Bioavailability of CBD in Human Trial -- CFN Media

CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering Lexaria Bioscience Corp....

GWPH : 133.93 (+1.04%)
LXRP : 1.7100 (-1.72%)
LXX.CN : 2.290 (-0.43%)
Cannabis Companies Set to Explode, at any Moment

HENDERSON, NV / ACCESSWIRE / August 3, 2018 / On June 25, the FDA approved London-based GW Pharma's Epidiolex, a drug containing CBD as its active ingredient, to treat two rare and severe forms of epilepsy,...

GWPH : 133.93 (+1.04%)
Emerging Legal Cannabis Market Expected to Grow Significantly

According to research published by Technavio, the legal cannabis market is projected to grow at a CAGR of about 24% by 2021. Increasing popularity of CBD oil is one of the primary growth factors for the...

IIPR : 34.43 (-2.02%)
CLSH : 1.1300 (-3.42%)
TAP : 67.89 (+1.06%)
EMHTF : 2.1100 (-3.21%)
GWPH : 133.93 (+1.04%)
Data Shows Global Cannabis Market Could Eclipse USD 30 Billion by 2021

According to a report published by Forbes, Brightfield Group estimates that the global cannabis industry was worth USD 7.7 Billion at the end of 2017 and is projected to cross the USD 30 Billion mark by...

CLSH : 1.1300 (-3.42%)
APHQF : 7.8797 (-1.75%)
TLRY : 29.27 (+0.58%)
GWPH : 133.93 (+1.04%)
CGC : 30.92 (-3.71%)
Free Technical Briefing on Drug Makers Stocks -- GW Pharma, AbbVie, AstraZeneca, and Bristol-Myers Squibb

If you want a free Stock Review on GWPH, ABBV, AZN, and BMY sign up now at https://stocktraderreport.com/registration/. On Wednesday, July 25, 2018, with all sectors in the green at the end of the trading...

AZN : 37.96 (-1.27%)
GWPH : 133.93 (+1.04%)
ABBV : 98.22 (+0.79%)
BMY : 61.11 (+1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

See More Share

Trade GWPH with:

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

2nd Resistance Point 137.14
1st Resistance Point 135.53
Last Price 133.93
1st Support Level 131.31
2nd Support Level 128.70

See More

52-Week High 164.76
Fibonacci 61.8% 138.65
Last Price 133.93
Fibonacci 50% 130.59
Fibonacci 38.2% 122.53
52-Week Low 96.42

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar